Colorectal Cancer Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Colorectal Cancer Therapeutics Landscape

Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Pfizer Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Bayer AG
Amgen Inc.
Genentech, Inc.
Teva Pharmaceuticals Industries Ltd.
Ipsen Biopharmaceuticals, Inc.

Browse Key Market Insights with Data Illustration:

Colorectal Cancer Therapeutics Market Size & Share, Forecast Report 2036

In the News

Ipsen Biopharmaceuticals, Inc. completed the acquisition of Epizyme Inc. and expanded its oncology portfolio.
Novartis AG announced the promising clinical data for its investigational KRASG12C inhibitor JDQ443, an investigational selective, covalent, and orally bioavailable inhibitor at the annual meeting of the American Association for Cancer Research (AACR)

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of colorectal cancer therapeutics is evaluated at USD 22.14 Billion.

The colorectal cancer therapeutics market size was over USD 20.33 Billion in 2023 and is projected to exceed USD 69.36 Billion by the end of 2036, witnessing over 9.9% CAGR during the forecast period i.e., between 2024-2036. Worldwide increasing prevalence of cancer, emerging novel therapies for cancer treatment, significant research on novel drugs, and global surge in geriatric population are some major factors driving the growth of the market.

North America industry is anticipated to hold majority revenue share by 2036, driven by escalating incidences of colorectal cancer coupled with supportive government initiatives along with rising healthcare expenditure, rising number of colon cancer, and increasing awareness among people regarding the screening of colorectal cancer in the region.

Novartis AG, Pfizer Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Bayer AG, Amgen Inc., Genentech, Inc., Teva Pharmaceuticals Industries Ltd., Ipsen Biopharmaceuticals, Inc.

Colorectal Cancer Therapeutics Market - Top Companies and Manufacturers

Companies Dominating the Colorectal Cancer Therapeutics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the colorectal cancer therapeutics market market worth?

Why is the demand for colorectal cancer therapeutics market growing?

Which region dominated the majority of colorectal cancer therapeutics market industry share?

Who are the top colorectal cancer therapeutics market companies?